Alex Soriano

65PUBLICATIONS
145CO-AUTHORS
Predictive and prognostic markersInfectious agentsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 31, 2026
Evaluation of an early step-down (≤5 days) strategy from echinocandins to azole therapy for the treatment of invasive candidiasis.

|Jul 24, 2026
Biomarker-driven strategy for early discontinuation of empirical antifungal treatment in critically ill patients: the role of (1-3)-β-D-glucan using Wako® test.

|Jun 18, 2026
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study.

|Jun 12, 2026
Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

|May 27, 2026
Prescribing Patterns and Clinical Effectiveness of Ceftolozane/Tazobactam for ESBL-Producing Enterobacterales: A SPECTRA Real-World Multi-Country Analysis.

|May 20, 2026
Antibiotic therapy in febrile neutropenia in haematological patients: current considerations and future challenges.

Pageof 11

Frequent Collaborators

9 joint publications

Pedro Puerta-Alcalde

8 joint publications

Carolina Garcia-Vidal

6 joint publications

Genoveva Cuesta

5 joint publications

Marjan Wouthuyzen-Bakker